CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products for cancer and infectious disease, today announced the appointment of Julian Adams, Ph.D. as Executive Chairman. Dr. Adams, who recently stepped down as President of Research and Development at Infinity Pharmaceuticals, will oversee strategic and operational responsibilities, fund raising and drive R&D program development for the company.
